144 related articles for article (PubMed ID: 17696196)
1. FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes.
Goldstein M; Meller I; Orr-Urtreger A
Genes Chromosomes Cancer; 2007 Nov; 46(11):1028-38. PubMed ID: 17696196
[TBL] [Abstract][Full Text] [Related]
2. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
[TBL] [Abstract][Full Text] [Related]
4. Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.
Goldstein M; Meller I; Issakov J; Orr-Urtreger A
Neoplasia; 2006 May; 8(5):332-43. PubMed ID: 16790082
[TBL] [Abstract][Full Text] [Related]
5. Identification of BMP2 as an epigenetically silenced growth inhibitor in rhabdomyosarcoma.
Wolf S; Hagl B; Kappler R
Int J Oncol; 2014 May; 44(5):1727-35. PubMed ID: 24585058
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel gene NCRMS on chromosome 12q21 with differential expression between rhabdomyosarcoma subtypes.
Chan AS; Thorner PS; Squire JA; Zielenska M
Oncogene; 2002 May; 21(19):3029-37. PubMed ID: 12082533
[TBL] [Abstract][Full Text] [Related]
7. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.
Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC
J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
9. Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas.
Kurmasheva RT; Peterson CA; Parham DM; Chen B; McDonald RE; Cooney CA
Pediatr Blood Cancer; 2005 Apr; 44(4):328-37. PubMed ID: 15602708
[TBL] [Abstract][Full Text] [Related]
10. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.
Tonin PN; Scrable H; Shimada H; Cavenee WK
Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137
[TBL] [Abstract][Full Text] [Related]
11. Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression.
Chen Y; Takita J; Mizuguchi M; Tanaka K; Ida K; Koh K; Igarashi T; Hanada R; Tanaka Y; Park MJ; Hayashi Y
Genes Chromosomes Cancer; 2007 Apr; 46(4):348-58. PubMed ID: 17243166
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
13. Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction.
Frascella E; Rosolen A
Am J Pathol; 1998 Feb; 152(2):577-83. PubMed ID: 9466584
[TBL] [Abstract][Full Text] [Related]
14. Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries.
Schaaf GJ; Ruijter JM; van Ruissen F; Zwijnenburg DA; Waaijer R; Valentijn LJ; Benit-Deekman J; van Kampen AH; Baas F; Kool M
FASEB J; 2005 Mar; 19(3):404-6. PubMed ID: 15629888
[TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.
Wen XZ; Akiyama Y; Baylin SB; Yuasa Y
Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833
[TBL] [Abstract][Full Text] [Related]
16. FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.
de Traux De Wardin H; Cyrta J; Dermawan JK; Guillemot D; Orbach D; Aerts I; Pierron G; Antonescu CR
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23232. PubMed ID: 38607246
[TBL] [Abstract][Full Text] [Related]
17. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
Gattenloehner S; Dockhorn-Dworniczak B; Leuschner I; Vincent A; Müller-Hermelink HK; Marx A
J Mol Diagn; 1999 Nov; 1(1):23-31. PubMed ID: 11272905
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma.
Iolascon A; Faienza MF; Coppola B; Rosolen A; Basso G; Della Ragione F; Schettini F
Genes Chromosomes Cancer; 1996 Apr; 15(4):217-22. PubMed ID: 8703847
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.
Seyed M; Dimario JX
J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970
[TBL] [Abstract][Full Text] [Related]
20. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
